DBV Technologies (DBVT) Equity Average (2016 - 2026)

DBV Technologies (DBVT) reported Equity Average of $188.4 million for Q1 2026, up 1143.23% year-over-year from $15.2 million in Q1 2025, and up 69.95% quarter-over-quarter from $110.8 million in Q4 2025.

DBV Technologies (DBVT) Equity Average (2016 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 11 years of Equity Average data on file, last reported at $188.4 million in Q1 2026.

  • Equity Average for Q1 2026 came in at $188.4 million, up 1143.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $188.4 million (up 1143.23% YoY), and the FY2025 annual result was $98.1 million, up 17.07% from the prior year.
  • Equity Average grew to $188.4 million in Q1 2026 per DBVT's latest filing, from $110.8 million in the prior quarter.
  • Over five years, Equity Average peaked at $228.2 million in Q3 2022 and troughed at $15.2 million in Q1 2025.
  • A 5-year average of $123.4 million and a median of $125.9 million in 2024 frame the typical range for Equity Average.
  • The sharpest annual moves came in 2025 and 2026: Equity Average plunged 87.97% in 2025, then jumped 1143.23% in 2026.
  • A 5-year view of Equity Average shows it stood at $203.3 million in 2022, then plunged by 30.09% to $142.1 million in 2023, then plunged by 71.34% to $40.7 million in 2024, then soared by 172.19% to $110.8 million in 2025, then jumped by 69.95% to $188.4 million in 2026.
  • Business Quant data shows DBVT's Equity Average at $188.4 million in Q1 2026, $110.8 million in Q4 2025, and $69.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 3.50 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 783.14 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.76 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.01 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 21.35 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.01 Bn
9 Abivax 91.96 Bn 91.96 Bn - 516.41 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 188.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 188.35 Mn
Dec 31, 2025 110.83 Mn
Sep 30, 2025 69.54 Mn
Jun 30, 2025 44.56 Mn
Mar 31, 2025 15.15 Mn
Dec 31, 2024 40.72 Mn
Sep 30, 2024 66.56 Mn
Jun 30, 2024 95.37 Mn
Mar 31, 2024 125.92 Mn
Dec 31, 2023 142.09 Mn
Sep 30, 2023 154.12 Mn
Jun 30, 2023 171.67 Mn
Mar 31, 2023 186.77 Mn
Dec 31, 2022 203.25 Mn
Sep 30, 2022 228.23 Mn
Jun 30, 2022 163.24 Mn
Mar 31, 2022 90.67 Mn
Dec 31, 2021 108.08 Mn
Sep 30, 2021 129.96 Mn
Jun 30, 2021 156.10 Mn